LKB1 expression reverses the tumorigenicity of L02 cells

Liang,Xiaoyan; Xu,Ge; Gao,Qing; Tao,Xiaohong

doi:10.3892/or.2016.4900

LKB1 expression reverses the tumorigenicity of L02 cells

Authors:
- Xiaoyan Liang
- Ge Xu
- Qing Gao
- Xiaohong Tao
View Affiliations

Affiliations: Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China, Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: June 22, 2016 https://doi.org/10.3892/or.2016.4900
Pages: 1055-1061

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The tumor-suppressor liver kinase B1 (LKB1), a highly conserved and ubiquitously expressed protein kinase, plays a critical role in tumorigenesis. In the present study, we revealed that human hepatic L02 cells had severely impaired endogenous LKB1 expression as gauged by western blot, northern blot and RT-PCR analyses. Stable ectopic expression of LKB1 in L02 cells resulted in decreased cell growth, hypophosphorylation of Rb, and marked attenuation of colony formation on soft agar. Inoculation of L02 cells into immunocompromised mice resulted in the development of subcutaneous tumors, which could be completely abrogated by ectopic LKB1 expression. The tumors that formed in the mouse model recapitulated the histopathological features of hepatocellular carcinoma under the microscope. Our results jointly suggest that severely compromised endogenous LKB1 expression in the L02 cell line may confer to L02 cells tumor-initiating capacities in vivo and in vitro, and ectopic LKB1 expression antagonizes the tumorigenic properties of L02 cells. Our findings imply that caution may be needed to interpret the results obtained on the widely used human hepatic L02 cell line. The L02 cell line may be a new model to define the cellular mechanisms of liver transformation, and to unravel the molecular mechanisms underlying the growth suppressive effect of LKB1.

View Figures

View References

1	McGarrity TJ and Amos C: Peutz-Jeghers syndrome: Clinicopathology and molecular alterations. Cell Mol Life Sci. 63:2135–2144. 2006. View Article : Google Scholar : PubMed/NCBI
2	Rustgi AK: The genetics of hereditary colon cancer. Genes Dev. 21:2525–2538. 2007. View Article : Google Scholar : PubMed/NCBI
3	Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Höglund P, et al: A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 391:184–187. 1998. View Article : Google Scholar : PubMed/NCBI
4	Hearle N, Schumacher V, Menko FH, Olschwang S, Boardman LA, Gille JJ, Keller JJ, Westerman AM, Scott RJ, Lim W, et al: Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res. 12:3209–3215. 2006. View Article : Google Scholar : PubMed/NCBI
5	Ji H, Ramsey MR, Hayes DN, Fan C, Mcnamara K, Kozlowski P, Torrice C, Wu MC, Shimamura T, Perera SA, et al: LKB1 modulates lung cancer differentiation and metastasis. Nature. 448:807–810. 2007. View Article : Google Scholar : PubMed/NCBI
6	Zhou J, Huang W, Tao R, Ibaragi S, Lan F, Ido Y, Wu X, Alekseyev YO, Lenburg ME, Hu GF, et al: Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells. Oncogene 2. 8:1993–2002. 2009. View Article : Google Scholar
7	Fenton H, Carlile B, Montgomery EA, Carraway H, Herman J, Sahin F, Su GH and Argani P: LKB1 protein expression in human breast cancer. Appl Immunohistochem Mol Morphol. 14:146–153. 2006. View Article : Google Scholar : PubMed/NCBI
8	Sanchez-Cespedes M: A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene. 26:7825–7832. 2007. View Article : Google Scholar : PubMed/NCBI
9	Ylikorkala A, Rossi DJ, Korsisaari N, Luukko K, Alitalo K, Henkemeyer M and Mäkelä TP: Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science. 293:1323–1326. 2001. View Article : Google Scholar : PubMed/NCBI
10	Jishage K, Nezu J, Kawase Y, Iwata T, Watanabe M, Miyoshi A, Ose A, Habu K, Kake T, Kamada N, et al: Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis. Proc Natl Acad Sci USA. 99:8903–8908. 2002. View Article : Google Scholar : PubMed/NCBI
11	Williams T and Brenman JE: LKB1 and AMPK in cell polarity and division. Trends Cell Biol. 18:193–198. 2008. View Article : Google Scholar : PubMed/NCBI
12	Shackelford DB and Shaw RJ: The LKB1-AMPK pathway: Metabolism and growth control in tumour suppression. Nat Rev Cancer. 9:563–575. 2009. View Article : Google Scholar : PubMed/NCBI
13	Partanen JI, Tervonen TA, Myllynen M, Lind E, Imai M, Katajisto P, Dijkgraaf GJ, Kovanen PE, Mäkelä TP, Werb Z, et al: Tumor suppressor function of Liver kinase B1 (Lkb1) is linked to regulation of epithelial integrity. Proc Natl Acad Sci USA. 109:E388–E397. 2012. View Article : Google Scholar : PubMed/NCBI
14	Yeh HJ, Chu TH and Shen TW: Ultrastructure of continuously cultured adult human liver cells. Acta Biol Exp Sinica. 14:361–365. 1980.
15	Li CY, Cao CZ, Xu WX, Cao MM, Yang F, Dong L, Yu M, Zhan YQ, Gao YB, Li W, et al: Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure. Gut. 59:817–826. 2010. View Article : Google Scholar
16	Tao YM, Huang JL, Zeng S, Zhang S, Fan XG, Wang ZM, Yang HX, Yuan XH, Wang P, Wu F, et al: BTB/POZ domain-containing protein 7: Epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma. Hepatology. 57:2326–2337. 2013. View Article : Google Scholar : PubMed/NCBI
17	Wan X, Xu C, Lin Y, Lu C, Li D, Sang J, He H, Liu X, Li Y and Yu C: Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 64:925–932. 2016. View Article : Google Scholar
18	Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao Y, Li Y, Zeng T, Hu J, Zhang L, et al: HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene. 32:3296–3305. 2013. View Article : Google Scholar : PubMed/NCBI
19	Liang X, Wang P, Gao Q and Tao X: Exogenous activation of LKB1/AMPK signaling induces G₁ arrest in cells with endogenous LKB1 expression. Mol Med Rep. 9:1019–1024. 2014.PubMed/NCBI
20	Liang X, Wang P, Gao Q, Xiang T and Tao X: Endogenous LKB1 knockdown accelerates G₁/S transition through p53 and p16 pathways. Cancer Biol Ther. 9:156–160. 2010. View Article : Google Scholar : PubMed/NCBI
21	Tiainen M, Ylikorkala A and Mäkelä TP: Growth suppression by Lkb1 is mediated by a G₁ cell cycle arrest. Proc Natl Acad Sci USA. 96:9248–9251. 1999. View Article : Google Scholar
22	Lee SM, Choi JE, Na YK, Lee EJ, Lee WK, Choi YY, Yoon GS, Jeon HS, Kim DS and Park JY: Genetic and epigenetic alterations of the LKB1 gene and their associations with mutations in TP53 and EGFR pathway genes in Korean non-small cell lung cancers. Lung Cancer. 81:194–199. 2013. View Article : Google Scholar : PubMed/NCBI
23	Tiainen M, Vaahtomeri K, Ylikorkala A and Mäkelä TP: Growth arrest by the LKB1 tumor suppressor: Induction of p21^WAF1/CIP1. Hum Mol Genet. 11:1497–1504. 2002. View Article : Google Scholar : PubMed/NCBI
24	Gopinath P and Ghosh SS: Apoptotic induction with bifunctional E. coli cytosine deaminase-uracil phosphoribosyltransferase mediated suicide gene therapy is synergized by curcumin treatment in vitro. Mol Biotechnol. 39:39–48. 2008. View Article : Google Scholar
25	Giacinti C and Giordano A: RB and cell cycle progression. Oncogene. 25:5220–5227. 2006. View Article : Google Scholar : PubMed/NCBI
26	Lee CJ, Jang JH, Lee JY, Lee MH, Li Y, Ryu HW, Choi KI, Dong Z, Lee HS, Oh SR, et al: Aschantin targeting on the kinase domain of mammalian target of rapamycin suppresses epidermal growth factor-induced neoplastic cell transformation. Carcinogenesis. 36:1223–1234. 2015. View Article : Google Scholar : PubMed/NCBI
27	George SH, Milea A, Sowamber R, Chehade R, Tone A and Shaw PA: Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis. Oncogene. 35:59–68. 2016. View Article : Google Scholar
28	Okon IS, Coughlan KA, Zhang C, Moriasi C, Ding Y, Song P, Zhang W, Li G and Zou MH: Protein kinase LKB1 promotes RAB7-mediated neuropilin-1 degradation to inhibit angiogenesis. J Clin Invest. 124:4590–4602. 2014. View Article : Google Scholar : PubMed/NCBI
29	Gao Y, Zhang W, Han X, Li F, Wang X, Wang R, Fang Z, Tong X, Yao S, Li F, et al: YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression. Nat Commun. 5:46292014. View Article : Google Scholar : PubMed/NCBI
30	Tanwar PS, Mohapatra G, Chiang S, Engler DA, Zhang L, Kaneko-Tarui T, Ohguchi Y, Birrer MJ and Teixeira JM: Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer. Carcinogenesis. 35:546–553. 2014. View Article : Google Scholar :
31	Kavsan VM, Iershov AV and Balynska OV: Immortalized cells and one oncogene in malignant transformation: Old insights on new explanation. BMC Cell Biol. 12:232011. View Article : Google Scholar : PubMed/NCBI
32	Sebbagh M, Olschwang S, Santoni M-J and Borg J-P: The LKB1 complex-AMPK pathway: The tree that hides the forest. Fam Cancer. 10:415–424. 2011. View Article : Google Scholar : PubMed/NCBI
33	Alessi DR, Sakamoto K and Bayascas JR: LKB1-dependent signaling pathways. Annu Rev Biochem. 75:137–163. 2006. View Article : Google Scholar : PubMed/NCBI
34	Pineau P, Marchio A, Nagamori S, Seki S, Tiollais P and Dejean A: Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesis. Hepatology. 37:852–861. 2003. View Article : Google Scholar : PubMed/NCBI
35	Berger AH, Knudson AG and Pandolfi PP: A continuum model for tumour suppression. Nature. 476:163–169. 2011. View Article : Google Scholar : PubMed/NCBI
36	Qiu W, Schönleben F, Thaker HM, Goggins M and Su GH: A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition in head and neck squamous cell carcinoma. Oncogene. 25:2937–2942. 2006. View Article : Google Scholar : PubMed/NCBI
37	Gomaa AI, Khan SA, Toledano MB, Waked I and Taylor-Robinson SD: Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J Gastroenterol. 14:4300–4308. 2008. View Article : Google Scholar : PubMed/NCBI
38	Nakau M, Miyoshi H, Seldin MF, Imamura M, Oshima M and Taketo MM: Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res. 62:4549–4553. 2002.PubMed/NCBI
39	Jain D: Tissue diagnosis of hepatocellular carcinoma. J Clin Exp Hepatol. 4(Suppl 3): S67–S73. 2014. View Article : Google Scholar